Skip to main content

Select Drug Profiles

Practice Management

Paying for Cancer Care: Economic Models Start to Emerge, Dovetailing Healthcare Reform

Caroline Helwick

Practice Management

Increased Patient Cost-Sharing, Weak US Economy, and Poor Health Habits: Implications for Employers and Insurers

Melinda C. Haren, RN, Kirk McConnell, Arthur F. Shinn, PharmD, FASCP

Stakeholder Perspective

The Cost-Sharing Conundrum: Greater Stakeholder Collaboration Needed

by Paul Anthony Polansky, BSPharm, MBA

Practice Management

Obesity: Effective Treatment Requires Change in Payers' Perspective

Rhonda Greenapple, MSPH, Jackie Ngai, MS

Stakeholder Perspective

Payers' Incentives Are Not Aligned to Address the Obesity Epidemic

by Jeff Januska, PharmD

Practice Management

Health Insurance Premium Increases for the 5 Largest School Districts in the United States, 2004-2008

John R. Cantillo, MBA

Stakeholder Perspective

Health Insurance Premium Increases for Large Employers

by F. Randy Vogenberg, PhD, FASHP

Original Research

Evolving Trends in Insulin Delivery: In Pursuit of Improvements in Diabetes Management

Firas Akhrass, MD, Nancy Skinner, RN, Kimberly Boswell, MD, Luther B. Travis, MD

Stakeholder Perspective

Diabetes: An Epidemic of Disastrous Proportions

by James V. Felicetta, MD

Original Research

Healthcare Costs Associated with Switching from Brand to Generic Levothyroxine

Michael Katz, PharmD, Joseph Scherger, MD, MPH, Scott Conard, MD, Leslie Montejano, CCRP, Stella Chang, MPH

Stakeholder Perspective

Health Insurance Premium Increases for Large Employers

by Michael S. Jacobs, RPh

Practice Management

Pay-for-Performance Initiatives: Modest Benefits for Improving Healthcare Quality

Amit Sura, MD, MBA, Nirav R. Shah, MD,MPH

Stakeholder Perspective

The Many Challenges of Pay-for-Performance Programs

by Steven T. Kmucha, MD, JD

Practice Management

Pharmacogenomics and Drug Development

Michael F. Murphy, MD, PhD

Practice Management

First Anti-Inflammatory Generic Drug Promising New Therapy for Diabetes

Dalia Buffery, MA, ABD

The Cardiovascular Pipeline: ACC 2010 Features Late-Stage Drugs

Page 240 of 244
Results 2391 - 2400 of 2438